A composition comprising:

  • (a) a pharmaceutically effective amount of reboxetine; and selected from the group consisting of clozapine, olanzapine, risperidone and mixtures thereof
  • (b) a pharmaceutically effective amount of one or more neuroleptic agents or a pharmaceutically effective salt thereof is provided.

    		•
     
    Web www.patentalert.com

    < Nucleic acids and proteins with growth hormone activity

    < Patient lifting apparatus

    > Plasmin variants and uses thereof

    > 1,6-naphthyridine derivatives and their use to treat diabetes and related disorders
    ~ 00220